|
SAND |
Quarterly Listing Statement - July 31, 2020 (Q2) |
Déclaration d'inscription trimestrielle |
26/09/2020 |
 Open Filing (714.14 Ko) |
|
SHP |
VIF 2020 |
Formulaire de procuration |
25/09/2020 |
Open Filing (80.65 Ko) |
|
SHP |
PROXY 2020 |
Formulaire de procuration |
25/09/2020 |
Open Filing (69.09 Ko) |
|
SHP |
NOTICE OF MEETING 2020 |
Avis de convocation |
25/09/2020 |
Open Filing (139.24 Ko) |
|
SHP |
INFORMATION CIRCULAR 2020 |
Management Proxy / circulaire d'information |
25/09/2020 |
Open Filing (461.96 Ko) |
|
VP |
Vodis Pharmaceuticals Inc. - Statement of Executive Compensation for Years Ended March 31, 2020 and March 31, 2019 |
Autre |
25/09/2020 |
Open Filing (489.95 Ko) |
|
VP |
Vodis Pharmaceuticals Inc. - Statement of Executive Compensation for Years Ended March 31, 2018 and March 31, 2017 |
Autre |
25/09/2020 |
Open Filing (543.82 Ko) |
|
TE |
Top Exploration Provides Coporate Update; Appoints New CEO |
Communiqué de presse |
25/09/2020 |
Open Filing (145.52 Ko) |
|
EDGM |
Form 5 - Quarterly Statement Q3 July 2020 |
Déclaration d'inscription trimestrielle |
25/09/2020 |
Open Filing (22.59 Mo) |
|
WIKI |
August Monthly Progress Report |
Rapport d'activité mensuel |
25/09/2020 |
Open Filing (125.97 Ko) |
